Lund University is celebrating 350 years. Read more on lunduniversity.lu.se

Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Immune responses against fibronectin modified by lipoprotein oxidation and their association with cardiovascular disease.

Author:
  • Pontus Dunér
  • Fong To
  • Ragnar Alm
  • Isabel Goncalves
  • Gunilla Nordin Fredrikson
  • Bo Hedblad
  • Göran Berglund
  • J Nilsson
  • Eva Bengtsson
Publishing year: 2009
Language: English
Pages: 593-603
Publication/Series: Journal of Internal Medicine
Volume: Feb 14.
Document type: Journal article
Publisher: Wiley-Blackwell

Abstract english

Abstract. Dunér P, To F, Alm R, Gonçalves I, Fredrikson GN, Hedblad B, Berglund G, Nilsson J, Bengtsson E (Malmö University Hospital, Lund University, Lund, Sweden). Immune responses against fibronectin modified by lipoprotein oxidation and their association with cardiovascular disease. J Intern Med 2009; doi: 10.1111/j.1365-2796.2008.02067.xObjectives. Accumulation and subsequent oxidation of LDL in the arterial wall are considered as key events in the development of atherosclerosis. We have investigated the possibility that LDL oxidation results in release of aldehydes that modify surrounding matrix proteins and that this may target immune responses against the plaque extracellular matrix and modulate the disease progression. Results. Using custom-made ELISAs we demonstrate that human plasma contains autoantibodies against aldehyde-modified fibronectin (FN) and to a lesser extent also other extracellular matrix proteins including collagen type I, type III, and tenascin-C. Immunohistochemistry and western blot analysis showed that aldehyde-modified FN is present in human atherosclerotic plaques and that aldehydes generated by oxidation of LDL formed adducts with FN in vitro. We also demonstrate that aldehyde-modification of FN results in a loss of its ability to promote basal secretion of cytokines and growth factors from cultured macrophages without affecting the ability of the cells to respond to stimulation with LPS. A prospective clinical study demonstrated that subjects that subsequently developed acute myocardial infarction or sudden cardiac death had lower baseline levels of autoantibodies against aldehyde-modified FN than matched controls. Conclusions. These observations demonstrate that oxidation of LDL in the arterial wall may lead to aldehyde-modification of surrounding extracellular matrix proteins and that these modifications may affect macrophage function and activate autoimmune responses of pathophysiological importance for the development of atherosclerosis.

Keywords

  • Cardiac and Cardiovascular Systems

Other

Published
  • Experimental Cardiovascular Research Unit
  • Cardio-vascular Epidemiology
  • Internal Medicine
  • ISSN: 1365-2796
E-mail: fong.to [at] med.lu.se

Biomedical analyst

Experimental Cardiovascular Research Unit

+46 40 39 12 25

91-12-047

33

Lund University Diabetes Centre, CRC, SUS Malmö, Entrance 72, House 91:12. SE-205 02 Malmö. Telephone: +46 40 39 10 00